The death panels here will do similar things
Are these Doctors members of Boko Haram??
‘
Pretty amazing how they create a vaccine which addresses 2 of the 100+ strains and then market it like its a cure all.
Figures the Gates would be involved.
For those of you on Freerepublic that don’t remember RICK PERRY the PRETEND CONSERVATIVE ex-governor of Texas, ordered every Texas schoolgirl over 13 to be injected with Guardasil
If you don’t believe me, just google Rick Perry and Guardasil
We fought him and the Texas House/Senate overruled him.
Unbelieveable
possibly of interest ping...
Speaking in general, a drug, treatment or vaccine has to be tested on kids if it is going to be used on kids.
Lots of drugs get tested in India. Some of the latest drugs, surgical techniques, etc., get vetted in India before they are adopted in the West. Nothing new here.
This entire article is extremely misleading and sensationalistic.
No regulatory body will approve a drug or vaccine for use in a specific age group if it has not been tested in that age group. If a company wants to market a vaccine for use in pre-teen girls, they’d better have reams of data showing that the vaccine was tested in pre-teen girls. Otherwise, the FDA (or foreign equivalent) won’t even consider the application for marketing approval. If that company gets approval to sell for pre-teen girls, and it wants to market to pre-teen boys, as well, it has to test the drug or vaccine in pre-teen boys. Also, if the company wants to change something about the drug—for instance, it wants to change the pill formulation from a tablet to a capsule—it has to do all of the Phase testing as if it is a new drug.
Prior to human testing, drugs and vaccines are tested in a number of animals and also in biochemical assays. If those test results look good, they move on to Phase 1 human tests. This typically involves several dozen to over 100 subjects, and tests only for safety. If found safe in Phase 1, the drug or vaccine goes on to Phase 2, the dose-finding studies. These are larger than Phase 1, usually a few hundred subjects. After dosage has been determined in Phase 2, the drug or vaccine goes on to Phase 3 efficacy studies, which involves thousands of test subjects. Typically, several studies are going on at once. By the time all of that testing is done, ten or twenty thousand people might have been study subjects. This testing takes a decade or longer, and getting market approval takes a couple more years after testing is complete—that is, if the FDA is satisfied with the data, which usually is not the case.
The short story is that human testing is both routine and necessary for any drug or vaccine to be approved for marketing. And this process is very expensive... it can take hundreds of millions, if not billions, of dollars to develop a drug to market phase.
Testing is not complete when the drug gets FDA approval, either. Once it hits the market, data must be collected in order to detect rare side effects that were too rare to show up in the pre-approval tests. (A 1 per 50,000 adverse event probably won’t be seen in a test of 4,000 volunteers.)